Prognostic significance of RBP2-H1 variant of JARID1B in melanoma

[1] Xiang Y(2007)JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer Proc Natl Acad Sci U S A 104 19226-19231

[2] Zhu Z(2015)Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and P16 expression in invasive ductal carcinoma of the breast Genet Mol Res 14 5417-5426

[3] Han G(2016)Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448 BMC Cancer 16 160-12739

[4] Ye X(2015)JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells Oncotarget 6 12723-2472

[5] Xu B(2016)Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27 J Exp Clin Cancer Res 35 37-777

[6] Peng Z(2015)Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer Tumour Biol 36 2465-100

[7] Zhao LH(2014)JARID1B is a luminal lineage-driving oncogene in breast cancer Cancer Cell 25 762-182

[8] Liu HG(2014)KDM5B is overexpressed in gastric cancer and is required for gastric cancer cell proliferation and metastasis Am J Cancer Res 5 87-7142

[9] Bamodu OA(2016)Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma Int J Mol Med 38 172-1257

[10] Huang WC(2015)JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression Tumour Biol 36 7133-594

[1] Xiang Y(2007)JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer Proc Natl Acad Sci U S A 104 19226-19231

[2] Zhu Z(2015)Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and P16 expression in invasive ductal carcinoma of the breast Genet Mol Res 14 5417-5426

[3] Han G(2016)Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448 BMC Cancer 16 160-12739

[4] Ye X(2015)JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells Oncotarget 6 12723-2472

[5] Xu B(2016)Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27 J Exp Clin Cancer Res 35 37-777

[6] Peng Z(2015)Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer Tumour Biol 36 2465-100

[7] Zhao LH(2014)JARID1B is a luminal lineage-driving oncogene in breast cancer Cancer Cell 25 762-182

[8] Liu HG(2014)KDM5B is overexpressed in gastric cancer and is required for gastric cancer cell proliferation and metastasis Am J Cancer Res 5 87-7142

[9] Bamodu OA(2016)Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma Int J Mol Med 38 172-1257

[10] Huang WC(2015)JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression Tumour Biol 36 7133-594